Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 10, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jeff Jones Maintained (zura) at Buy with Increased Target to $21 on, May 10th, 2024
Jeff Jones of Oppenheimer, Maintained "Zura Bio Limited" (ZURA) at Buy with Increased Target from $16 to $21 on, May 10th, 2024.
Jeff has made no other calls on ZURA in the last 4 months.
There is 1 other peer that has a rating on ZURA. Out of the 1 peers that are also analyzing ZURA, 0 agree with Jeff's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jeff
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $26 on, Friday, May 3rd, 2024
